Aktuelle Publikationen
2021
Leder C, Suk M, Lorenz S, Rastogi T, Peifer, C, Kietzmann M, Jonas D, Buck M, Pahl A, Kümmerer K: Reducing Environmental Pollution by Antibiotics through Design for Environmental Degradation. ACS Sustainable Chemistry & Engineering. 2021, 9, 28, 9358–9368. https://doi.org/10.1021/acssuschemeng.1c02243
Jonas D, Reuter S, Klassen S, Weber S, Buck M, Giani T, Rossolini GM, Grundmann H.: Evaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases. Sci Rep. 2021 Jun 23;11(1):13150.doi: 10.1038/s41598-021-92336-3. https://pubmed.ncbi.nlm.nih.gov/34162904/
2020
Pompilio A, Ranalli M, Piccirilli A, Perilli M, Vukovic D, Savic B, Krutova M, Drevinek P, Jonas D, Fiscarelli EV, Tuccio Guarna Assanti V, Tavío MM, Artiles F, Di Bonaventura G: Biofilm Formation among Stenotrophomonas maltophilia Isolates Has Clinical Relevance: The ANSELM Prospective Multicenter Study. Microorganisms. 2020 Dec 27;9(1):49. doi: 10.3390/microorganisms9010049. https://pubmed.ncbi.nlm.nih.gov/33375493/
Liu T, Bolle E, Chirila T, Buck, M, Jonas D, Suzuki S, Smith T, Shastri VP, Dargaville T, Forget A: Transparent, Pliable, Antimicrobial Hydrogels for Ocular Wound Dressings. Applied Sciences (Switzerland). 2020, 10(21), 7548; https://doi.org/10.3390/app10217548
Götting T, Reuter S, Jonas D, Hentschel R, Henneke P, Klotz D, Hock S, Wolkewitz M, Blümel B, Häcker G, Grundmann H, Mutters N: Protocol for a prospective cohort study: Prevention of Transmissions by Effective Colonisation Tracking in Neonates (PROTECT-Neo). BMJ Open. 2020 Sep 21;10(9):e034068. doi: 10.1136/bmjopen-2019-034068. https://pubmed.ncbi.nlm.nih.gov/32958479/
Khaledi A, Weimann A, Schniederjans M, Asgari E, Kuo TH, Oliver A, Cabot G, Kola A, Gastmeier P, Hogardt M, Jonas D, Mofrad MR, Bremges A, McHardy AC, Häussler S.: Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics. EMBO Mol Med. 2020 Mar 6;12(3):e10264.doi: 10.15252/emmm.201910264. Epub 2020 Feb 12. https://pubmed.ncbi.nlm.nih.gov/32048461/
2019
Pala-Ozkok I, Ubay-Cokgor E, Jonas D, Orhon D.: Kinetic and microbial response of activated sludge community to acute and chronic exposure to tetracycline. J Hazard Mater. 2019 Apr 5;367:418-426.doi: 10.1016/j.jhazmat.2018.12.094. Epub 2018 Dec 24. https://pubmed.ncbi.nlm.nih.gov/30611034/
Pompilio A, Ranalli M, Piccirilli A, Perilli M, Vukovic D, Savic B, Krutova M, Drevinek P, Jonas D, Fiscarelli EV, Tuccio Guarna Assanti V, Tavío MM, Artiles F, Di Bonaventura G.: Biofilm Formation among Stenotrophomonas maltophilia Isolates Has Clinical Relevance: The ANSELM Prospective Multicenter Study. Microorganisms. 2020 Dec 27;9(1):49.doi: 10.3390/microorganisms9010049. https://pubmed.ncbi.nlm.nih.gov/33375493/
Götting T, Reuter S, Jonas D, Hentschel R, Henneke P, Klotz D, Hock S, Wolkewitz M, Blümel B, Häcker G, Grundmann H, Mutters N.: Protocol for a prospective cohort study: Prevention of Transmissions by Effective Colonisation Tracking in Neonates (PROTECT-Neo). BMJ Open. 2020 Sep 21;10(9):e034068.doi: 10.1136/bmjopen-2019-034068. https://pubmed.ncbi.nlm.nih.gov/32958479/
2018
Pala-Ozkok I, Ubay-Cokgor E, Jonas D, Orhon D: Kinetic and microbial response of activated sludge community to acute and chronic exposure to tetracycline. J Hazard Mater. 2019 Apr 5;367:418-426. Epub 2018 Dec 24. pubmed/30611034
Anderson AC, Andisha H, Hellwig E, Jonas D, Vach K, Al-Ahmad A: Antibiotic Resistance Genes and Antibiotic Susceptibility of Oral Enterococcus faecalis Isolates Compared to Isolates from Hospitalized Patients and Food. Adv Exp Med Biol, 2018; 1057: 47-62. pubmed/28601926
Rizek CF, Jonas D, Garcia Paez JI, Rosa JF, Perdigão Neto LV, Martins RR, Moreno LZ, Rossi Junior A, Levin AS, Costa SF: Multidrug-resistant Stenotrophomonas maltophilia: Description of new MLST profiles and resistance and virulence genes using whole-genome sequencin. J Glob Antimicrob. Resist. 2018 Dec;15:212-214. Epub 2018 Jul 20. pubmed/30036694
Pala-Ozkok I, Kor-Bicakci G, Çokgör EU, Jonas D, Orhon D3.: Microbial endogenous response to acute inhibitory impact of antibiotics. Environ Technol, 2018; 39 (13): 1626-1637. pubmed/28537126
Klotz D, Schreiner M, Falcone V, Jonas D, Kunze M, Weber A, Fuchs H, Hentschel R:High-Temperature Short-Time Treatment of Human Milk for Bacterial Count Reduction. Front Pediatr. 2018 Nov 27;6:359. pubmed/30538974
Pfeifer Y, Werner G, Körber-Irrgang B, Jonas D, Kresken M: Escherichia coli ST1421 harbouring the hybrid extended-spectrum β-lactamase CTX-M-64 from a German patient. J Glob Antimicrob Re, 2018; 12: 167-168. Online
2017
Becker E, Schmidt TSB, Bengs S, Poveda L, Opitz L, Atrott K, Stanzel C, Biedermann L, Rehman A, Jonas D, von Mering C, Rogler G, Frey-Wagner I: Effects of oral antibiotics and isotretinoin on the murine gut microbiota. Int J Antimicrob Ag, 2017; 50 (3): 342-351. pubmed/28689869
El-Shazly DA, Nasef SA, Mahmoud FF, Jonas D: Expanded spectrum β-lactamase producing Escherichia coli isolated from chickens with colibacillosis in Egypt. J Poult Sci, 2017; 96 (7): 2375-2384. pubmed/28339845
Reinhardt H, Trittler R, Eggleton AG, Wöhrl S, Epting T, Buck M, Kaiser S, Jonas D, Duyster J, Jung M, Hug MJ, Engelhardt M: Paving the Way for Dose Banding of Chemotherapy: An Analytical Approach. J Natl Compr Canc Ne, 2017; 15 (4): 484-493. pubmed/28404759
2016
Forget A, Arya N, Randriantsilefisoa R, Miessmer F, Buck M, Ahmadi V, Jonas D, Blencowe A, Shastri VP: Nonwoven Carboxylated Agarose-Based Fiber Meshes with Antimicrobial Properties. Biomacromolecules, 2016; 17 (12): 4021-4026. Online
Oberle M, Wohlwend N, Jonas D, Maurer FP, Jost G, Tschudin-Sutter S, Vranckx K, Egli A: The Technical and Biological Reproducibility of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) Based Typing: Employment of Bioinformatics in a Multicenter Study. Plos One, 2016; 11 (10). Online
Anderson A.C., Jonas D., Huber I., Karygianni L., Wölber J., Hellwig E., Arweiler N., Vach K., Wittmer A., Al-Ahmad A: Enterococcus faecalis from Food, Clinical Specimens, and Oral Sites: Prevalence of Virulence Factors in Association with Biofilm Formation. Front. Microbiol.6:1534. doi: 10.3389/fmicb.2015.01534. 2016 pubmed/26793174
Kor-Bicakci G, Pala-Ozkok I, Ural A, Jonas D, Orhon D, Ubay-Cokgor E: Is the chronic impact of sulfamethoxazole different for slow growing culture? The effect of culture history. Bioresour Technol. 2016 Jan 25;206:65-76. doi: 10.1016/j.biortech.2016.01.069. pubmed/26849198
Götting T, Klassen S, Jonas D, Benk Ch, Serr A, Wagner D, Ebner W: Heater-cooler units: contamination of crucial devices in cardiothoracic surgery. J Hosp Infect, 2016; 93 (3): 223-228. pubmed/27101883
2015
Hos NJ, Rieg S, Kern WV, Jonas D, Fowler Jr VG, Higgins PG, Seifert H, Kaasch AJ: Amino acid alterations in fibronectin binding protein A (FnBPA) and bacterial genotype are associated with cardiac-device related infection in Staphylococcus aureus bacteremia. Journal of Infection 70: 153-159; 2015, doi: 10.1016/j.jinf.2014.09.005 (IF: 4.017) online
Bäumlisberger M, Youssar L, Schilhabel MB, Jonas D: Influence of a non-hospital medical care facility on antimicrobial resistance in wastewater. PLoS One. 10(3):e0122635. doi: 10.1371/journal.pone.0122635. 2015. (IF: 3.503) pubmed/25821977
2014
Kor-Bicakcia G, Pala-Ozkok I, Rehman A, Jonas D, Ubay-Cokgor E, Orhon D: Chronic impact of sulfamethoxazole on acetate utilization kinetics and population dynamics of fast growing microbial culture. Bioresource Technol, 2014; 166: 219-228. pubmed/24908607
Rieg S, Saborowski V, Kern WV, Jonas D, Bruckner-Tuderman L Hofmann SC: Expression of the sweat-derived innate defence antimicrobial peptide dermcidin is not impaired in Staphylococcus aureus colonization or recurrent skin infections. Clin Exp Dermatol, 2014; 39 (2): 209-212. pubmed/23782241
2013
Anderson AC, Al-Ahmad A, Elamin F, Jonas D, Mirghani Y, Schilhabel M, Karygianni ., Hellwig E, Rehman A: Comparison of the Bacterial Composition and Structure in Symptomatic and Asymptomatic Endodontic Infections Associated with Root-Filled Teeth Using Pyrosequencing. PLoS ONE 8(12): e84960. doi:10.1371/journal.pone.0084960. 2013. online
Biedermann, Zeitz J, Mwinyi J, Sutter-Minder E, Rehman A, Ott SJ, Steurer-Stey C, Frei A, Frei P, Scharl M, Loessner MJ, Vavricka SR, Fried M, Schreiber S, Schuppler M, Rogler G: Smoking Cessation induces profound changes in the composition of the intestinal microbiota in humans. Plos One, 2013; 8 (3) (online): e59260. online
Couturier-Maillard A, Secher T, Rehman A, Normand S, De Arcangelis A, Haesler R, Huot L, Grandjean T, Bressenot A, Delanoye-Crespin A, Gaillot O, Schreiber S, Lemoine Y, Ryffel B, Hot D, Nùñez G, Chen G, Rosenstiel P, Chamaillard M: NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest, 2013; 123 (2): 700-711. pubmed/23281400
Rieg S., Jonas D., Kaasch A.J., Porzelius C., Peyerl-Hoffmann G., Theilacker C., Küpper M.F., Schneider C., Seifert H., Kern W.V. Microarray-Based Genotyping and Clinical Outcomes of Staphylococcus aureus Bloodstream Infection: An Exploratory Study. PLoS One. 8(8):e71259. doi: 10.1371/journal.pone.0071259. 2013. online
Rieg S, Saborowski V, Kern WV, Jonas D, Bruckner-Tuderman L, Hofmann SC: Expression of the sweat-derived innate defence antimicrobial peptide dermcidin is not impaired in Staphylococcus aureus colonization or recurrent skin infections. Clin Exp Dermatol. 2013 Jun 20. doi: 10.1111/ced.12189. pubmed/23782241
Pala-Ozkok I., Rehman A., Kor-Bicakcia G., Urala A., Schilhabel M.B., Ubay-Cokgor E., Jonas D., Orhon D. Effect of sludge age on population dynamics and acetate utilization kinetics under aerobic conditions. Bioresource Technology 143: 68-75; 2013. pubmed/23777847
Rieg S, Kaasch AJ, Wehrle J, Hofmann SC, Szymaniak-Vits M, Saborowski V, Jonas D, Kalbacher H, Seifert H, Kern WV: Susceptibility of clinical Staphylococcus aureus isolates to innate defense antimicrobial peptides. Microbes Infect. 13:: 761-765. pubmed/21473929
2012
Pala-Ozkok I, Rehman A, Yagci N, Ubay-Cokgor E, Jonas D, Orhon D: Characteristics of Mixed Microbial Culture at Different Sludge Ages: Effect on Variable Kinetics for Substrate Utilization. Bioresource Technology 126: 274-282; 2012. dx.doi.org/10.1016/j.biortech.2012.08.115. pubmed/23079414
Millet A *, Lamy E *, Jonas D, Stintzing F, Mersch-Sundermann V, Merfort I: Fermentation Enhances the Biological Activity of Allium cepa Bulb Extracts. J Agr Food Chem, 2012; 60: 2148-2156. pubmed/22300474
Rehman A, Heinsen FA, Koenen ME, Venema K, K necht H, Hellmig S, Schreiber S, Ott SJ.: Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine. Bmc Microbiol, 2012; 12: 47. pubmed/22452835
Rehman A, Hu J, Ott S J, Grössner-Schieber B: Microbial Community Composition on Modified Dental Implant Surfaces. Int J Oral Max Surg, 2012; 27 (4): 811-819. pubmed/22848882
2011
Monecke S, Coombs G, Shore AC, Coleman DC, Akpaka P, Borg M, Chow H, Ip M, Jatzwauk L, Jonas D, Kadlec K, Kearns A, Laurent F, O´Brien FG, Pearson J, Ruppelt A, Schwarz S, Scicluna E, Slickers P, Tan H-L, Weber S, Ehricht R: A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS ONE 6(4): e17936. doi:10.1371/journal.pone.0017936; 2011. online
Gatermann S, Jonas D, Mersch-Sundermann V: Epidemiologie und Transmission multiresistenter gramnegativer Erreger in deutschen Kliniken. Klinikarzt, 2011; 40 (3): 134-137. online
Lück Ch, Jonas D, Mersch-Sundermann V: Legionella Pneumonien in Kliniken Prävention und Infektionskontrolle wasserbürtiger Infektionen. Klinikarzt, 2011; 40 (3): 146-150. online
Rieg S, Kaasch AJ, Wehrle J, Hofmann SC, Szymaniak-Vits M, Saborowski V, Jonas D, Kalbacher H, Seifert H, Kern WV.: Susceptibility of clinical Staphylococcus aureus isolates to innate defense antimicrobial peptides. Microbes Infect, 2011; 13 (8-9): 761-765. pubmed/21473929
Vasileuskaya-Schulz Z, Kaiser S, Maier T, Kostrzewa M, Jonas D: Delineation of Stenotrophomonas spp. by multi-locus sequence analysis and MALDI-TOF mass spectrometry. Syst Appl Microbiol, 2011; 34 (1): 35-9. pubmed/21247714
2010
Al-Ahmad A, Maier J, Follo M, Spitzmüller B, Wittmer A, Hellwig E, Hübner J, Jonas D: Food-borne enterococci integrate into oral biofilm: an in vivo study. J Endod. 36:1812-1819; 2010. pubmed/20951293
Kruse E-B, Conrad A, Wenzler-Röttele S, Jonas D, Dettenkofer M, Wolkewitz M, Meyer E, Serr A: Extended-spectrum ß-lactamase-producing Enterobacter cloacae in mobile dialysis units in the medical and surgical departments of a university hospital: a case–control study. J. Hosp. Infect. 75: 33–36; 2010. pubmed/20347508
Wendt C, Schütt S, Dalpke AH, Konrad M, Mieth M, Trierweiler-Hauke B, Weigand MA, Zimmermann S, Biehler K, Jonas D: First Outbreak of Klebsiella pneumoniae Carbapenemase (KPC) Producing Klebsiella pneumoniae in Germany. Eur J Clin Microbiol Infect Dis. 29: 563–570; 2010. pubmed/20213255
2009
Theilacker C, Jonas D, Huebner J, Bertz H, Kern WV: Outcomes of Invasive Infection due to Vancomycin-Resistant Enterococcus faecium during a Recent Outbreak. Infection. Infection.37: 540-543; 2009. pubmed/19669085
Monecke S, Ehricht R, Slickers P, Wiese N, Jonas D: Intra-strain variability of methicillin-resistant Staphylococcus aureus strains ST228-MRSA-I and ST5-MRSA-II. Eur J Clin Microbiol Infect Dis. 28:1383–1390; 2009. pubmed/19693551
Shahid M, Sobia F, Singh A, Malik A, Khan HM, Jonas D, Hawkey PM: Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive update. Crit Rev Microbiol. 35: 81-108; 2009. pubmed/19514910
Kaiser S, Biehler K, Jonas D: A Stenotrophomonas maltophilia Multilocus Sequence Typing Scheme for Inferring Population Structure. J. Bacteriol. 191: 2934-2943; 2009. online
2008
Erlandsson M, Gill H, Nordlinder D, Giske CG, Jonas D, Nilsson LE, Walther S, Hanberger H: Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs. Scand J Infect Dis., 40: 487-494. 2008. pubmed/18584536
Jonas D, Meyer E, Schwab F, Grundmann H: Genodiversity of Resistant Pseudomonas aeruginosa Isolates in Relation to Antimicrobial Usage Density and Resistance Rates in Intensive Care Units. Infect Control Hosp Epidemiol. 29: 350-357; 2008. pubmed/18269329
2007
Schmidt-Hieber M, Blau IW, Schwartz S, Uharek L, Weist K, Eckmanns T, Jonas D, Ruden H, Thiel E, Brandt C: Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients. Int J Hematol. 86:158-162; 2007. pubmed/17875531
Buchbeiträge
2012
Jonas D: Stenotrophomonas maltophilia In: GERMAP 2012 Antibiotika-Resistenz und -Verbrauch Rheinbach: Antiinfectives Intelligence Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH, 2014. Germap 2012 online
Kongressbeiträge
Jonas D, Rehman A: High Throughput Sequencing of Outbreak Strains for Investigating Fluoroquinolone Resistance Mechanisms in Stenotrophomonas maltophilia by Comparative Transcriptomics Abstracts of the 23rd ECCMID, 2013, 2013; 0 (23rd ECCMID, Berlin, Germany 27 - 30 April 2013, European Society of Clinical Microbiology and Infectious Diseases).
D. Jonas, S. Rieg, C. Schneider, A. Kaasch, H. Seifert, W. Kern. Distribution of virulence factors and clonal complexes in Staphylococcus aureus isolates from nosocomial blood stream infections 21st European Congress of Clinical Microbiology and Infectious Diseases, Milan, 2011.
Z. Vasileuskaya-Schulz, S. Kaiser, D. Jonas Multilocus Sequence Analysis reveals genetic relationships between Stenotrophomonas spp., Pseudomonas beteli and Pseudoxanthomonas dokdonensis. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, 2010.
D. Jonas, I. Götz, E. Schmidt-Eisenlohr. Comparative Activity of Doripenem and Other Antipseudomonal Antibiotics against European Clinical Resistant Isolates of P. aeruginosa and Acinetobacter spp. Joint 48th Annual ICAAC/IDSA 46th Annual Meeting Washington DC, 2008.
D. Jonas, Hartung, D., Zugravu, R., Götz, I., Schmidt-Eisenlohr, E.: In vitro Susceptibility of Non-fermentative Gram-negative Strains from European ICU-Patients against Carbapenems and Other Antipseudomonal Drugs. 60. Tagung der DGHM, Dresden, 2008.
S. Kaiser, K. Biehler, D. Jonas. A multi-locus sequence typing scheme for Stenotrophomonas maltophilia. 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, 2008.
S. Kaiser, K. Biehler, D. Jonas.: Investigation of Stenotrophomonas maltophilia by Multi Locus Sequence Typing. 60. Tagung der DGHM, Dresden, 2008.
S. Kaiser, K. Biehler, D. Jonas. A multi-locus sequence typing scheme for Stenotrophomonas maltophilia. 18th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, 2008.
D. Jonas, A. Buchwald, A., K. Biehler, C. Schneider, S. Schütt, C. Wendt. CTX-M Escherichia coli with reduced susceptibility to imipenem. 59. Tagung der DGHM, Göttingen, 2007.
D. Jonas, E. Meyer, F. Schwab, F.D. Daschner. Differences in mutation rate between phylogenetic groups of Escherichia coli. 17th European Congress of Clinical Microbiology and Infectious Diseases, Munich, 2007.
OA Prof. Dr. Daniel Jonas
Telefon: +49 (0) 761 270-82730 / 82880
Telefax: +49 (0) 761 270-82030 / 82830
daniel.jonas@uniklinik-freiburg.de